The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Market Value Trend Is Expected For The In-Vitro Diagnostics Instruments Market From 2026 To 2030?
The in-vitro diagnostics instruments market has experienced robust expansion in recent years. It is projected to grow from $61.09 billion in 2025 to $67.18 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.0%. This growth in the past can be attributed to factors such as the increasing prevalence of chronic diseases, improvements in hospital laboratory infrastructure, advancements in diagnostic reagents, a rising awareness for early disease detection, and various government healthcare initiatives.
The in-vitro diagnostics instruments market is projected to experience swift expansion over the coming years. This market is anticipated to reach $99.44 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.3%. The expansion during the projected timeframe stems from various factors, including technological progress in molecular diagnostics, the rise of personalized medicine, the incorporation of AI into diagnostics, the broadening of healthcare services in emerging markets, and the increasing need for home-based diagnostic tools. Key developments expected within this period encompass the spread of point-of-care testing, advancements in personalized diagnostics, the wider uptake of rapid molecular testing, the integration of remote patient monitoring, and the development of miniaturized lab instruments.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=29107&type=smp
Which Growth Factors Are Strengthening The In-Vitro Diagnostics Instruments Market Landscape?
The increasing occurrence of chronic and lifestyle-related diseases is predicted to boost the expansion of the in vitro diagnostics instruments market moving forward. These conditions refer to enduring health issues primarily influenced by daily routines, behaviors, and environmental factors, such as heart disease, diabetes, obesity, and certain cancers. The surge in chronic and lifestyle-related diseases stems from sedentary lifestyles and unhealthy dietary habits. Solutions for in vitro diagnostics instruments are experiencing heightened demand as the rapid spread of chronic and lifestyle-related diseases compels companies to adopt early detection and monitoring tools for enhanced disease management. For instance, in 2024, according to the American Action Forum, a US-based non-profit, center-right think tank, chronic diseases remain a significant public health concern in the U.S., with nearly 60 percent of adults living with at least one condition, 40 percent managing multiple conditions, and prevalence expected to nearly double by 2050. Additionally, the chronic disease treatment market is anticipated to reach approximately USD 38.02 billion by 2034, marking a substantial increase from USD 9.74 billion in 2025. Hence, the rising prevalence of chronic and lifestyle-related diseases is propelling the demand for the in vitro diagnostics instruments market.
Which Segment Groups Define The In-Vitro Diagnostics Instruments Market Landscape?
The in-vitro diagnostics instruments market covered in this report is segmented –
1) By Product Type: Clinical Chemistry, Immunoassay, Molecular Diagnostics, Hematology, Microbiology, Coagulation, Other Product Types
2) By Application: Infectious Diseases, Cancer, Cardiology, Nephrology, Autoimmune Diseases, Other Applications
3) By End User: Hospitals And Diagnostic Laboratories, Academic And Research Institutes, Point-Of-Care Settings, Blood Banks, Pharmaceutical And Biotechnology Companies, Other Healthcare Facilities
Subsegments:
1) By Clinical Chemistry: Automated Clinical Chemistry Analyzers, Semi-Automated Clinical Chemistry Analyzers, Point-Of-Care Clinical Chemistry Devices
2) By Immunoassay: Enzyme-Linked Immunosorbent Assay (ELISA) Systems, Chemiluminescence Immunoassay (CLIA) Analyzers, Radioimmunoassay (RIA) Systems
3) By Molecular Diagnostics: Polymerase Chain Reaction (PCR) Systems, Next-Generation Sequencing (NGS) Platforms, Deoxyribonucleic Acid Microarrays, Isothermal Amplification Devices
4) By Hematology: Automated Hematology Analyzers, Manual Hematology Analyzers, Hemostasis Analyzers, Coagulation Analyzers
5) By Microbiology: Microbial Identification Systems, Antibiotic Susceptibility Testing (AST) Systems, Blood Culture Systems, Automated Microbial Analyzers.
6) By Coagulation: Coagulometers, Platelet Function Analyzers, Thromboelastography (TEG) Systems, Point-Of-Care Coagulation Devices
7) By Other Product Types: Point-Of-Care Diagnostic Devices, Miscellaneous Laboratory Instruments
What Trends Are Influencing The In-Vitro Diagnostics Instruments Market?
Leading companies within the in-vitro diagnostics instruments market are concentrating on developing advanced products, such as digital polymerase chain reaction (dPCR) systems, to achieve highly precise and sensitive nucleic acid quantification for sophisticated diagnostics. Digital polymerase chain reaction (dPCR) systems serve as advanced diagnostic tools, precisely quantifying DNA or RNA molecules by segmenting samples into thousands of individual reactions, ensuring highly accurate and sensitive detection. For instance, in September 2024, QIAGEN N.V., a Netherlands-based biotechnology company, introduced the QIAcuityDx Digital PCR System. This expanded its digital PCR portfolio into clinical diagnostics, with a specific focus on oncology testing. The QIAcuityDx is a fully integrated, automated system specifically engineered for clinical testing in oncology, utilizing a cartridge-based workflow that minimizes hands-on time. This system also incorporates automated analysis and reporting software, which facilitates the rapid and accurate detection of genetic biomarkers crucial for cancer diagnosis and therapy monitoring, requiring minimal operator intervention.
Who Are The Businesses Driving Activity In The In-Vitro Diagnostics Instruments Market?
Major companies operating in the in-vitro diagnostics instruments market are F. Hoffmann-La Roche Ltd, Danaher Corporation, Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers AG, Becton Dickinson and Company, Sysmex Corporation, Bio-Rad Laboratories Inc, Agilent Technologies, Hologic Inc, Qiagen N.V., Illumina Inc, Ortho Clinical Diagnostics, Beckman Coulter Inc, Mindray Medical International Limited, Horiba Ltd, Randox Laboratories Ltd, DiaSorin S.p.A., Werfen S.A., Trinity Biotech plc
Access The Complete In-Vitro Diagnostics Instruments Market Report:
Which Region Commands The Largest Share Of The In-Vitro Diagnostics Instruments Market?
North America was the largest region in the in-vitro diagnostics instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro diagnostics instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a In-Vitro Diagnostics Instruments Market Report for Deeper Competitive Insights
Browse Through More Reports Similar to the Global In-Vitro Diagnostics Instruments Market 2026, By The Business Research Company
Intravenous Iv Hydration Therapy Market Report 2026
Intravenous Immunoglobulin Market Report 2026
https://www.thebusinessresearchcompany.com/report/intravenous-immunoglobulin-global-market-report
Intravenous Infusion Pumps Market Report 2026
https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model